Your prediction
Fresenius SE & Co. KGaA ADR Stock
A loss of -1.740% shows a downward development for Fresenius SE & Co. KGaA ADR.
Pros and Cons of Fresenius SE & Co. KGaA ADR in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Fresenius SE & Co. KGaA ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Fresenius SE & Co. KGaA ADR | -1.740% | -5.785% | 12.871% | 0.000% | -3.390% | 56.164% | 0.000% |
| Fresenius Medical Care AG & Co KGaA ST | 0.390% | -3.137% | -3.183% | -4.655% | 0.000% | -9.483% | -41.353% |
| Universal Health Services B | -2.030% | -1.333% | 11.278% | -3.268% | -22.917% | 25.424% | 14.198% |
| HCA Holdings Inc. | 0.370% | -2.481% | 7.797% | 3.369% | -13.158% | 41.907% | 67.208% |
News
Fresenius Medical Care AG & Co. KGaA Q2 Earnings Call Highlights
Key Points
- Interested in Fresenius Medical Care AG & Co. KGaA? Here are five stocks we like better.
- Fresenius Medical Care reported solid Q2 results, with organic revenue up 5% and operating
Quest Diagnostics Q2 Earnings Call Highlights
Key Points
- Interested in Quest Diagnostics Incorporated? Here are five stocks we like better.
- Quest Diagnostics posted strong Q2 results, with revenue up 10.2% to $3.04 billion and adjusted